ORUKA THERAPEUTICS INC(ORKA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ORKA ORUKA THERAPEUTICS INC

Not Yet Opened 08-26 16:00:00 EDT

99.44

-2.38

-2.34%

盘后99.44

+0.000.00%

19:41 EDT

High102.48	Low98.24	Vol526.83K
Open101.30	D1 Closing101.82	Amplitude4.16%
Mkt Cap6.58B	Tradable Cap5.63B	Total Shares66.21M
T/O52.83M	T/O Rate0.93%	Tradable Shares56.65M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":99.44,"timestamp":1787774400000,"preClose":101.82,"halted":0,"volume":526825,"hourTrading":{"tag":"盘后","latestPrice":99.44,"preClose":99.44,"latestTime":"19:41 EDT","volume":40287,"amount":4006195.02,"timestamp":1787787684455,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0233745825967393,"floatShares":56648688,"shares":66209699,"eps":-2.024183,"marketStatus":"Not Yet Opened","change":-2.38,"latestTime":"08-26 16:00:00 EDT","open":101.3,"high":102.48,"low":98.2401,"amount":52833977.99225,"amplitude":0.041641,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.024183,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":0,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":101.82,"preHourTrading":{"tag":"盘前","latestPrice":101.4,"preClose":101.82,"latestTime":"09:29 EDT","volume":1577,"amount":161280.4208,"timestamp":1787750999999,"change":-0.42,"changeRate":-0.004125,"amplitude":0.063838},"postHourTrading":{"tag":"盘后","latestPrice":99.44,"preClose":99.44,"latestTime":"19:41 EDT","volume":40287,"amount":4006195.02,"timestamp":1787787684455,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.495297,"impliedVol":0.9954,"impliedVolPercentile":0.5936},"requestUrl":"/m/hq/s/ORKA","defaultTab":"news","newsList":[{"id":"2662794594","title":"Oruka Therapeutics Files Form 3 for Chief Commercial Officer Larry Todd Edwards","url":"https://stock-news.laohu8.com/highlight/detail?id=2662794594","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662794594?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:36","pubTimestamp":1787736989,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics files Form 3 for Chief Commercial Officer Larry Todd EdwardsOruka Therapeutics filed a Form 3 naming Larry Todd Edwards as chief commercial officer.Disclaimer:This news brief was cr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL681D65:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205703","title":"Oruka Therapeutics Names Todd Edwards Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205703","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205703?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601676,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics names Todd Edwards chief commercial officerOruka Therapeutics named Todd Edwards chief commercial officer, effective Aug. 24, 2026.Edwards joins from Arcutis Biotherapeutics, where ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL6VDQwY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","FTXH","LU0738911758.USD","PPH","LU2357627491.SGD","LU1551013342.USD","BK4550","IDNA","IXJ","LU0689626769.HKD","LU1718418525.SGD","LU1923622614.USD","XLV","LU2347655156.SGD","LU0456855351.SGD","RXL","IE00B3PB1722.GBP","INCY","PJP","BCDF","FHLC","IE00BN0W2W23.USD","GLAM","LU0124676726.USD","IYH","LU0395794307.EUR","LU0949170772.SGD","LU2125909247.SGD","NDAQ","LU2129689431.USD","LU0965508806.USD","MEDX","IE00B2B36J28.USD","VHT","JDOC","LU1496350502.SGD","LU1291159041.SGD","LU2210149790.SGD","LU2210150020.SGD","ORKA","LU0820561909.HKD","ARQT","ABBV","LU0211327993.USD","LU1057294990.SGD","SG9999014021.USD","TRUH","AGNG","LU0098860793.USD","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662920503","title":"Press Release: Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662920503","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662920503?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601660,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (\"Oruka\") (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA","BK4007","BK4139","LENZ","LU0109394709.USD","R","BK4022","BK4539","LU0320765992.SGD","LU0889565916.HKD","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661248500","title":"Oruka Therapeutics (ORKA) Files $1b Shelf As Investors Weigh A Pricey Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2661248500","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661248500?lang=en_us&edition=fundamental","pubTime":"2026-08-23 17:16","pubTimestamp":1787476604,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics (ORKA) has filed a universal shelf registration for up to US$1 billion in common and preferred stock, depositary shares and warrants. This filing gives the company flexibility to raise capital when needed.\nSee our latest analysis for Oruka Therapeutics.\nOruka Therapeutics shares trade at US$107.96 after a 78.12% 90 day share price return and a very large 1 year total shareholder return, with recent gains pointing to strong momentum despite a softer 7 day share price return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-orka/oruka-therapeutics/news/oruka-therapeutics-orka-files-1b-shelf-as-investors-weigh-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-orka/oruka-therapeutics/news/oruka-therapeutics-orka-files-1b-shelf-as-investors-weigh-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","ISBC","BK4211","LU0320765992.SGD","BK4139","ORKA","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661297453","title":"Oruka Therapeutics Files $1 Billion Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2661297453","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661297453?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:29","pubTimestamp":1787344176,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics (ORKA) filed a registration statement Friday with the US Securities and Exchange Commission for the potential sale of up to $1 billion in securities in one or more offerings.The filing covers common and preferred stock, depositary shares and warrants.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4007","LU0889565916.HKD","LU0109394709.USD","LENZ","LU0320765992.SGD","BK4539","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659173451","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659173451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659173451?lang=en_us&edition=fundamental","pubTime":"2026-08-15 22:30","pubTimestamp":1786804224,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kodiak Sciences (KOD) and Oruka Therapeutics (ORKA) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-303?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-303?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","LU0320765992.SGD","LU0109394709.USD","KOD","BK4139","ORKA","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659241881","title":"Oruka Therapeutics SVP Finance Arjun Agarwal Disposes of 9,999 Common Shares Worth $1,067,833.92","url":"https://stock-news.laohu8.com/highlight/detail?id=2659241881","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659241881?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:46","pubTimestamp":1786744001,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics SVP Finance Arjun Agarwal disposes of 9,999 common shares worth $1,067,833.92Oruka Therapeutics SVP, Finance Arjun Agarwal exercised employee stock options to acquire 10,000 common ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLwHsPp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Oruka Therapeutics SVP Finance Arjun Agarwal Disposes of 9,999 Common Shares Worth $1,067,833.92","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA","BK4139","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658479925","title":"Oruka Therapeutics (ORKA) Has a New Rating from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2658479925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658479925?lang=en_us&edition=fundamental","pubTime":"2026-08-12 13:16","pubTimestamp":1786511771,"startTime":"0","endTime":"0","summary":"In a report released yesterday, David Nierengarten from Wedbush initiated coverage with a Buy rating on Oruka Therapeutics and a price target of $1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oruka-therapeutics-orka-has-a-new-rating-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oruka-therapeutics-orka-has-a-new-rating-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945664","title":"Analysts Are Bullish on These Healthcare Stocks: Oruka Therapeutics (ORKA), Zura Bio (ZURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945664","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945664?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:40","pubTimestamp":1786480811,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oruka Therapeutics (ORKA) and Zura Bio (ZURA) with b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-oruka-therapeutics-orka-zura-bio-zura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-oruka-therapeutics-orka-zura-bio-zura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","ORKA","ZURA","LU0889565916.HKD","LU0109394709.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919032","title":"Jefferies Keeps Their Buy Rating on Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919032","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919032?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:56","pubTimestamp":1786460185,"startTime":"0","endTime":"0","summary":"In a report released today, Roger Song from Jefferies maintained a Buy rating on Oruka Therapeutics, with a price target of $133.00. According to T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-keeps-their-buy-rating-on-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-keeps-their-buy-rating-on-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658477992","title":"Guggenheim Sticks to Their Buy Rating for Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658477992","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658477992?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:16","pubTimestamp":1786446969,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Yatin Suneja from Guggenheim reiterated a Buy rating on Oruka Therapeutics, with a price target of $200.00. The com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658096669","title":"Oruka Therapeutics Inc : Leerink Partners Raises Target Price to $179 from $162","url":"https://stock-news.laohu8.com/highlight/detail?id=2658096669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658096669?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:43","pubTimestamp":1786416226,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4471ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ORKA","LU0320765992.SGD","BK4139","LU0889565916.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658935621","title":"Oruka Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935621","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935621?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:59","pubTimestamp":1786363182,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryOruka Therapeutics IncORKA.OQreported a quarterly adjusted loss of 55 cents per share for the quarter ended June ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N4470RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","ORKA","BK4139","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658677933","title":"Earnings Flash (ORKA) Oruka Therapeutics Posts Q2 Loss $0.55 a Share, vs. FactSet Est of $0.53 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658677933","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658677933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:28","pubTimestamp":1786361285,"startTime":"0","endTime":"0","summary":"Earnings Flash (ORKA) Oruka Therapeutics Posts Q2 Loss $0.55 a Share, vs. FactSet Est of $0.53 Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938426","title":"Oruka Therapeutics Inc Q2 Net Income USD -41.206 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938426?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:11","pubTimestamp":1786360276,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXD71NWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938948","title":"Oruka Therapeutics Q2 FY26 Net Loss Widens to $41.2 Million; R&D Expenses Rise to $43.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938948","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938948?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:06","pubTimestamp":1786360006,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics Q2 FY26 net loss widens to $41.2 million; R&D expenses rise to $43.3 millionOruka posted a Q2 2026 net loss of $41.2 million, widening from $24.6 million a year earlier.R&D expenses","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL1G7yFc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA","BK4139","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938568","title":"Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938568","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938568?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:03","pubTimestamp":1786359780,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA5J6FFD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU0109394709.USD","BK4139","ORKA","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652294793","title":"Oruka Therapeutics Inc : Leerink Partners Raises Target Price to $162 from $120","url":"https://stock-news.laohu8.com/highlight/detail?id=2652294793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652294793?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:06","pubTimestamp":1784542006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M0AM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195106691","title":"Movement Alert｜Oruka Therapeutics Rises 9.43% in Regular Trading, Market Anticipates Key H2 Efficacy Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1195106691","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195106691?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:41","pubTimestamp":1784299318,"startTime":"0","endTime":"0","summary":"On July 17, Oruka Therapeutics rose 9.43% in regular trading, trading at approximately $91.14/share, with turnover of $120 million. The rally was driven by renewed market optimism surrounding the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651948694","title":"Oruka Therapeutics CMO Joana Goncalves Disposes of 7,000 Common Shares for $601,227.73","url":"https://stock-news.laohu8.com/highlight/detail?id=2651948694","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651948694?lang=en_us&edition=fundamental","pubTime":"2026-07-16 07:37","pubTimestamp":1784158632,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics CMO Joana Goncalves disposes of 7,000 common shares for $601,227.73Oruka Therapeutics Chief Medical Officer Joana Goncalves exercised 7,000 employee stock option and warrant shares ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDLbhxgBR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Oruka Therapeutics CMO Joana Goncalves Disposes of 7,000 Common Shares for $601,227.73","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.orukatx.com","stockEarnings":[{"period":"1week","weight":-0.0934},{"period":"1month","weight":0.1024},{"period":"3month","weight":0.7151},{"period":"6month","weight":1.8899},{"period":"1year","weight":5.7144},{"period":"ytd","weight":2.2808}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.0206},{"period":"6month","weight":0.1111},{"period":"1year","weight":0.1921},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.352941,"avgChangeRate":0.043718},{"month":2,"riseRate":0.388889,"avgChangeRate":-0.070079},{"month":3,"riseRate":0.388889,"avgChangeRate":-0.00265},{"month":4,"riseRate":0.611111,"avgChangeRate":0.112851},{"month":5,"riseRate":0.5,"avgChangeRate":0.08077},{"month":6,"riseRate":0.333333,"avgChangeRate":0.460115},{"month":7,"riseRate":0.555556,"avgChangeRate":0.025043},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.121897},{"month":9,"riseRate":0.352941,"avgChangeRate":-0.05799},{"month":10,"riseRate":0.470588,"avgChangeRate":-0.023177},{"month":11,"riseRate":0.647059,"avgChangeRate":0.007168},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.002826}],"exchange":"NASDAQ","name":"ORUKA THERAPEUTICS INC","nameEN":"ORUKA THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ORUKA THERAPEUTICS INC(ORKA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ORUKA THERAPEUTICS INC(ORKA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ORUKA THERAPEUTICS INC,ORKA,ORUKA THERAPEUTICS INC股票,ORUKA THERAPEUTICS INC股票老虎,ORUKA THERAPEUTICS INC股票老虎国际,ORUKA THERAPEUTICS INC行情,ORUKA THERAPEUTICS INC股票行情,ORUKA THERAPEUTICS INC股价,ORUKA THERAPEUTICS INC股市,ORUKA THERAPEUTICS INC股票价格,ORUKA THERAPEUTICS INC股票交易,ORUKA THERAPEUTICS INC股票购买,ORUKA THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ORUKA THERAPEUTICS INC(ORKA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ORUKA THERAPEUTICS INC(ORKA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction